Literature DB >> 28186225

VALORATE: fast and accurate log-rank test in balanced and unbalanced comparisons of survival curves and cancer genomics.

Victor Treviño1, Jose Tamez-Pena1.   

Abstract

SUMMARY: The association of genomic alterations to outcomes in cancer is affected by a problem of unbalanced groups generated by the low frequency of alterations. For this, an R package (VALORATE) that estimates the null distribution and the P -value of the log-rank based on a recent reformulation is presented. For a given number of alterations that define the size of survival groups, the log-rank density is estimated by a weighted sum of conditional distributions depending on a co-occurrence term of mutations and events. The estimations are accurately accelerated by sampling across co-occurrences allowing the analysis of large genomic datasets in few minutes. In conclusion, the proposed VALORATE R package is a valuable tool for survival analysis.
AVAILABILITY AND IMPLEMENTATION: The R package is available in CRAN at https://cran.r-project.org and in http://bioinformatica.mty.itesm.mx/valorateR . CONTACT: vtrevino@itesm.mx. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Mesh:

Year:  2017        PMID: 28186225     DOI: 10.1093/bioinformatics/btx080

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  4 in total

1.  Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer.

Authors:  Monica M Olcina; Nikolas G Balanis; Ryan K Kim; B Arman Aksoy; Julia Kodysh; Michael J Thompson; Jeff Hammerbacher; Thomas G Graeber; Amato J Giaccia
Journal:  Cell Rep       Date:  2018-12-26       Impact factor: 9.423

2.  Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.

Authors:  Victor Trevino
Journal:  Mol Genet Genomic Med       Date:  2019-07-11       Impact factor: 2.183

3.  Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.

Authors:  Xingchen Li; Fufen Yin; Yuan Fan; Yuan Cheng; Yangyang Dong; Jingyi Zhou; Zhiqi Wang; Xiaoping Li; Jianliu Wang
Journal:  Cancer Med       Date:  2020-12-22       Impact factor: 4.452

4.  Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.

Authors:  Han-Zhang Zhu; Wei-Jiang Zhou; Ya-Feng Wan; Ke Ge; Jun Lu; Chang-Ku Jia
Journal:  World J Gastroenterol       Date:  2020-02-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.